Quest Diagnostics Incorporated (0KSX)
LSE
243.31
+1.49 (+0.62%)
Closed
Oct 26, 2026
Day's Range
240.20247.19
52 wk Range
171.60256.06
Financial Statements - 0KSX - Quest Diagnostics Incorporated
Revenue
10.46B▲ 16.1%
Net Income
1.30B▲ 4.9%Net Margin 12.5%
EBITDA
1.72B▲ 6.5%
Free Cash Flow
1.77B▲ 12.8%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 10.46B | 9B | 8.84B | 8.18B |
| Cost of Goods | 6.64B | 5.45B | 5.45B | 5.11B |
| Gross Profit | 3.81B | 3.55B | 3.38B | 3.07B |
 Operating Expense | - | - | - | - |
| Operating Income | 1.26B | 1.20B | 1.06B | 957.40M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 1.30B | 1.25B | 1.14B | 915.92M |
| Income Tax | 5.45M | 8.17M | 24.17M | -10.79M |
| Net Income | 1.30B | 1.24B | 1.12B | 926.71M |
| EPS Basic | 1.06 | 1.02 | 0.92 | 0.76 |
| EPS Diluted | 1.06 | 1.02 | 0.92 | 0.76 |
| Basic Shares Outstanding | 1.23B | 1.23B | 1.23B | 1.22B |
| Diluted Shares Outstanding | 1.23B | 1.23B | 1.23B | 1.22B |
| Ebit | - | - | - | - |
| Ebitda | 1.72B | 1.61B | 1.51B | 1.17B |
| Net Income Continuous Operations | 1.30B | 1.24B | 1.12B | 926.71M |
| Minority Interests | 2.66M | 19.78M | 14.38M | 5.46M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
